Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

PCI Biotech: Annual Report 2017

PCI Biotech Holding
Posted on: 19 Mar 18

Oslo (Norway), March 19, 2018
The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2017 and the report is attached. The Annual Report 2017 is also available on the company's website

For further information, please contact:             
PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo       
Per Walday, CEO,, Mobile: +47 917 93 429  
Ronny Skuggedal, CFO,, Mobile: +47 940 05 757

This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

PCI Biotech Holding ASA Annual Report 2017

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: PCI Biotech Holding via GlobeNewswire

Last updated on: 20/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.